Document:

aafinancial8kex1010_462009.htm

     

    Exhibit
10.10

     

    
 

    Agreement

    

    

    This Agreement is entered into between
Apro Bio Pharmaceutical Corporation, a Colorado corporation (the "Company") and
David Olson (“Olson”), this 6th day of March, 2009 (“Effective
Date”).

    

    

    Recitals

    

    Whereas,
Olson was employed as an officer and director of the Company.

    

    Whereas,
Olson has resigned as an officer and director of the Company, and has made
claims against the Company for amounts due and owing to him.

    

    Whereas,
the parties desire to amicably resolve their outstanding issues.

    

    Agreement

    

    Now,
therefore, for good and valuable consideration, the receipt of which is hereby
acknowledged by both parties, the parties agree as follows:

    

    
      	
              1.  

            	
              Resignation.  Olson
      hereby acknowledges that he has resigned as an officer and director of the
      Company and affirms that he is no longer acting as an officer or director
      of the Company.

            

    

    

    
      	
              2.  

            	
              Payment.  In
      consideration of the agreements and subject to Olson’s performance of the
      undertakings set forth in this Agreement, the Company, in full and final
      settlement of all of Olson’s stated compensation claims, including any
      unpaid compensation, claim for severance, reimbursement of vacation or
      sick pay, or other compensation, or any other rights or obligations which
      may be asserted by Olson, agrees to make the following payments and
      additional consideration to Olson:

            

    

    

    
      	
              (a)  

            	
              The
      Company, shall pay to Olson $45,000 in cash by wire transfer due and
      payable on the closing date of financing by the Company in aggregate of at
      least One Hundred Fifty Thousand dollars ($150,000 USD) from the Effective
      Date.

            

    

    

    
      	
              (b)  

            	
              The
      Company shall issue to Olson 60,000 shares of the Company’s restricted
      common stock within five days of the closing date of the financing
      referenced in section 2(a) above, with a certificate of the issued shares
      to be delivered to Olson within thirty (30) days of the closing
      date.  Such shares shall not be sold until one year following
      the date of issuance.  Thereafter, such shares shall also be
      registered whenever any Company shares owned by its directors are included
      in a future Registration Statement.

            

    

    

    
      	
              (c)  

            	
              Upon
      execution of this Agreement, the Company will issue and take any other
      action necessary to ensure Olson will have a total of 50,000 vested
      warrants in the Company granted to Olson pursuant to one or more
      resolutions by the Company’s

            

    

    

    
      
        
          
             

            

          

           

        

        
          Page 1 of
5

          
            

          

        

        
           

        

      

    

    

    
      	
              (d)  

            	
              Board
      of Directors as additional compensation to Olson as a director of the
      Company.  Such warrants will be included in the Company’s next
      scheduled Registration Statement if any Company warrants owned by the
      Company’s directors are currently registered or, if no such warrants are
      currently registered, Olson’s warrants will be registered whenever any
      Company warrants owned by its directors are included in a future
      Registration Statement.

            

    

    

    
      	
              (e)  

            	
              Company
      shall grant to Olson or his designee any and all equity (e.g. options,
      warrants, shares or other equity position) that Company would have granted
      to Bathgate Capital Partners or its successors, assignees or designees
      upon the merger, spin out or other business combination relating to the
      “Cell Rejection” technology as it was referred to while Olson was an
      officer of the Company, if such business combination occurs within (12)
      months of the Effective Date.  Olson acknowledges no fees or
      other consideration will be due and owing to him if Bathgate Capital
      Partners or any of its directors, officers principals, or employees are
      not involved in any such business
combination.

            

    

    

    
      	
              3.  

            	
              Lock Up
      Agreement.  Olson agrees that he will execute a Lock Up
      Agreement in conjunction with the Company’s proposed merger upon the same
      terms and conditions as the officers, directors and owners of Bathgate
      Capital Partners for all of his shares other than the shares to be issued
      pursuant to Paragraph 2(b).  If Bathgate Capital Partners or any
      of its officers, directors, principals or owners obtains a modification or
      release from the restrictions placed on the transfer of Restricted
      Securities (as defined in the Lock Up Agreement), the Company shall
      provide immediate written notification thereof to Olson and he shall have
      the right to the same modification or release upon written notice to the
      Company.

            

    

    

    
      	
              4.  

            	
              Confidentiality.  Each
      party agrees not to, without the prior written consent of the other party,
      directly or indirectly disclose to any third party individual, corporation
      or other entity (other than the Company or its affiliates or each party’s
      respective officers, directors, representatives or employees entitled to
      such information) or use for their own or such another’s benefit, any
      information, whether or not reduced to written or other tangible form,
      which (a) is not generally known to the public or in the industry; (b) has
      been treated by the Company as confidential or proprietary; and (c) is of
      competitive advantage to the Company or any of its Affiliates (such
      information being referred to in this paragraph as "Confidential
      Information").  Confidential Information which becomes generally
      known to the public without violation of this Agreement or was disclosed
      to a party by a third party without an obligation of confidentiality to
      the other party shall cease to be subject to the restrictions of the
      Paragraph.  As used in this Agreement, the term “affiliate” or
      Affiliate” shall mean any entity that is at least fifty percent (50%)
      owned or controlled by a party, an entity which directly or indirectly
      owns or controls more than fifty (50%0) of the voting stock of a party, or
      any entity, the majority ownership of which is directly or indirectly
      common to the ownership of party.

            

    

    

    
      	
              5.  

            	
              Company
      property. Olson and the Company acknowledge that Olson is in
      possession of certain Company property, specifically, an HP docking
      station, flat computer screen, two book cases, and several computer
      accessories. . Olson may keep said property as his personal property
      provided all Company related files and documents contained or
      stored

            

    

    

    
      
        
          
            

          

           

        

        
          Page 2 of
5

          
            

          

        

        
           

        

      

    

    

    
      	
                

            	
              in
      said property are  returned to the Company.  The
      Company agrees to provide Olson with copies of all returned files and
      documents, to be delivered to his residence within seven (7) days of
      receipt. The Company further acknowledges that all computers and other
      office equipment in Olson’s possession are the property of
      Olson.  Upon execution of this Agreement, Olson shall return all
      other Company property to the Company, including all Confidential
      Information, books and records of the Company and any other property of
      the Company or its affiliates.  If Olson later discovers other
      Company property in his possession, Olson will notify the Company
      requesting instructions for shipment or destruction of such property.
      Company shall bear all costs related to the shipment or destruction of
      such property.

            

    

    

    
      	
              6.  

            	
              Non-Disparagement.

            

    

    

    
      	
              a.  

            	
              Olson
      agrees that he shall not make any disparaging statements about the Company
      or its affiliates or the directors, its officers or employees of any of
      them; provided that the provisions of this clause shall not apply to
      truthful testimony as a witness, compliance with other legal obligations,
      or truthful assertion of or defense against any claim of breach of this
      Agreement, or to his truthful statements or disclosures to officers or
      directors of the Company, and shall not require Olson to make false
      statements or disclosures.

            

    

    

    
      	
              b.  

            	
              The
      Company agrees that neither it nor its directors,  officers, nor
      employees of the Company nor any spokesperson for any of them shall make
      any disparaging statements about Olson; provided that the provisions of
      this clause shall not apply to truthful testimony as a witness, compliance
      with other legal obligations, truthful assertion of or defense against any
      claim of breach of this Agreement or truthful statements or disclosures to
      Olson, and shall not require false statements or disclosures to be
      made.

            

    

    

    
      	
              7.  

            	
              Releases.  Releases.  Except
      for a claim based upon a breach of this Agreement and the performance of
      the obligations contained herein, effective as of the receipt of all
      payments and consideration specified in Paragraph 2(a)-(c) above, the
      Olson Released Parties (as defined below) shall release the Company
      Released Parties (as defined below), and the Company Released Parties
      shall release the Olson Released Parties, from any and all claims, suits,
      demands, actions or causes of action of any kind or nature whatsoever
      (“Claims”), whether the underlying facts are known or unknown, which the
      Olson Released Parties or the Company Released Parties have or now claim,
      or might have or claim, pertaining to or arising out of Olson’s employment
      by the Company or his separation therefrom, or any breach or
      non-performance of any employment or other agreements between Olson and
      the Company, or under any local, state or federal common law, statute,
      regulation or ordinance, including without limitation those claims dealing
      with employment discrimination, including without limitation, Title VII of
      the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000e et seq., 42 U.S.C. §
      1981, Americans with Disabilities Act, or claims for breach of contract,
      for breach of fiduciary duty, for misrepresentation, for defamation, for
      wrongful discharge under the common law of any state, for infliction of
      emotional distress or for any other tort under the common law of any
      state.  This release shall run to and be binding upon the
      Company and each

            

    

    

    
      
        
          
            

          

           

        

        
          Page 3 of
5

          
            

          

        

        
           

        

      

    

    

    
      	
                

            	
              of
      its affiliates, and all predecessors, successors and assigns thereof and
      each of their members, trustees, partners, principals, members, directors,
      officers, trustees, employees, agents and attorneys, past or present (but
      only for their activities as members, trustees, partners, principals,
      members, directors, officers, trustees, employees, agents and attorneys
      for the Company), and all predecessors, successors, heirs and assigns
      thereof (collectively, "Company Released Parties") and to Olson, his
      affiliates, heirs, successors and assigns, and each of his employees,
      agents and attorneys (collectively, the Olson Released
      Parties).

            

    

    

    
      	
              8.  

            	
              Covenant
      Not to Sue.  To the maximum extent permitted by law, the
      Company and Olson covenant not to sue or to institute or cause to be
      instituted any action in any federal, state or local agency or court
      against the other party regarding the Claims covered by the release
      contained in paragraph 6 above (except to enforce the terms of this
      Agreement).  The covenants herein shall expire on March 11, 2009
      (extended to March 31, 2009), unless all payments under Paragraph 2(a)-(c)
      have been received by Olson at which time such covenants shall remain in
      effect with the releases of Paragraph 6.  If any party breaches
      the terms of the release and covenant not to sue, then the aggrieved party
      shall be entitled to recover its costs, including reasonable attorneys’
      fees incurred in defending such
action.

            

    

    

    
      	
              9.  

            	
              Modification.  No
      modification of this Agreement shall be valid unless signed by the party
      against whom such modification is sought to be
  enforced.

            

    

    

    
      	
              10.  

            	
              Legal
      Counsel.  Olson acknowledges that he has carefully read
      and fully understands the terms and provisions of this Agreement and all
      of their rights and obligations thereunder, has had an opportunity to be
      represented by legal counsel of his choosing prior to executing this
      Agreement which contains a general release and waiver and that his
      execution of this Agreement is
voluntary.

            

    

    

    
      	
              11.  

            	
              No
      Admission.  The parties agree that neither this Agreement
      nor performance hereunder constitutes an admission by any party of any
      violation of any federal, state or local law, regulation, common law, of
      any breach of any contract or any other wrongdoing of any
      type.

            

    

    

    
      	
              12.  

            	
              Entire
      Agreement.  This instrument constitutes the entire
      agreement between the parties.

            

    

    

    
      	
              13.  

            	
              Severability.  If
      any provision, section, subsection or other portion of this Agreement
      shall be determined by any court of competent jurisdiction to be invalid,
      illegal or unenforceable in whole or in part, and such determination shall
      become final, such provision or portion shall be deemed to be severed or
      limited, but only to the extent required to render the remaining
      provisions and portions of this Agreement enforceable.  This
      Agreement as thus amended shall be enforced so as to give effect of the
      intention of the parties insofar as that is possible.  In
      addition, the parties hereby expressly empower a court of competent
      jurisdiction to modify any term or provision of this Agreement to the
      extent necessary to comply with existing law and to enforce this Agreement
      as modified.

            

    

     

     

    

    
      
        
          
            

          

           

        

        
          Page 4 of
5

          
            

          

        

        
           

        

      

    

     

     

    
      

      
        	
                14.  

              	Governing
      Law.  This Agreement shall be construed in
      accordance with the laws of the State of
Colorado.

      

    

    

    
      	
              15.  

            	
              Counterparts.  This
      Agreement may be signed in multiple counterparts, each of which shall be
      deemed to be an original for all
purposes.

            

    

    

    

    IN WITNESS WHEREOF, the
parties have executed this Agreement on the date first above
written.

     

    
      

      

      
        
          
            
              
                
                  
                    
                      	 	
                              Apro
      Bio Pharmaceutical Corporation

                            	 
	 	 	 	 
	
                               

                            	
                              By:   
      

                            	/s/ Vicki D.E.
      Barone__________________	 
	 	
                              Printed
      Name:   

                            	
                              Vicki
      D.E. Barone____________________

                            	 
	 	
                              Its:  
      

                            	Chairman
      ___________________________	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	
                              Name:   

                            	 David Olson_________________________	 

                    

                  

                

              

            

          

        

      

      
        
        

      

       

    

    

    

    
      
        
          
             

            

          

           

        

        
          Page 5 of
5aafinancial8kex1011_462009.htm

    
       

      Exhibit
10.11

    Agreement

    

    

       This Agreement is entered
into between Apro Bio Pharmaceutical Corporation, a Colorado corporation (the
"Company") and David Floor (“Floor”), this 8th day of
January, 2009.

    

    Recitals

    

          
Whereas, Floor has been employed as an officer and director of the
Company pursuant to an employment agreement dated March 1st, 2006,
a copy of which is attached hereto as Exhibit A..

    

          
Whereas, Floor has agreed to resign as an officer and director of the
Company at the Closing Date (as hereinafter defined).

    

          
Whereas, the parties desire to amicably resolve their outstanding
issues.

    Agreement

    

          
Now, therefore, for good and valuable consideration, the receipt of which is
hereby acknowledged by both parties, the parties agree as
follows:

    

    
      	
              1.

            	
              Resignation.  Floor
      hereby resigns as an officer and director of the Company effective on the
      closing date (the “Closing Date) of the proposed merger between the
      Company and Across America Financial Services, Inc. pursuant to an
      Agreement and Plan of Merger dated November 17, 2008, and affirms that he
      is no longer acting as an officer or director of the
    Company.

            

    

    

    
      	
              2.

            	
              Payment.  In
      consideration of the agreements set forth in this Agreement, the Company,
      in full and final settlement of all of Floor’s stated and unstated claims,
      including any claim for severance, reimbursement of vacation or sick pay,
      or other compensation, or any other rights or obligations which may be
      asserted by Floor, agrees to make the following payment, and issue the
      shares provided for, to Floor (the “Payment and
  Issuance”):

            

    

    

    
      	
               
      

            	
              (a)

            	
              The
      Company, shall pay to Floor $95,000 in cash or certified funds within 5
      days of Closing Date. Such payments reflect $75,000 of compensation and
      reimbursement of $20,000 of
expenses.

            

    

    

    
      	
               
      

            	
              (b)

            	
              The
      Company shall issue to Floor 50,000 shares of the Company’s restricted
      common stock within 5 days of the Closing
Date.

            

    

    
      
      

    

    

    
      	
               
      

            	
              .

            

    

    
      	
              3.

            	
              Confidentiality.  Floor
      agrees that he will not, without the prior written consent of the Company,
      directly or indirectly disclose to any individual, corporation or other
      entity (other than the Company or its affiliates or their respective
      officers, directors or employees entitled to such information) or use for
      their own or such another’s benefit, any information, whether or not
      reduced to written or other tangible form, which (a) is not generally
      known to the public or in the industry; (b) has been treated by the
      Company as confidential or proprietary; and (c) is of competitive
      advantage to the Company or any of its Affiliates (such information being
      referred to in this paragraph as "Confidential
      Information").  Confidential Information which becomes generally
      known to the public without violation of this Agreement shall cease to be
      subject to the restrictions of this

            

    

    

    
      	
              4.

            	
              Non-Disparagement.

            

    

    

    
      	
               
      

            	
              a.

            	
              Effective
      the Closing Date, Floor agrees that he shall not make any disparaging
      statements about the Company or its affiliates or the directors, officers
      or employees of any of them; provided that the provisions of this clause
      shall not apply to truthful testimony as a witness, compliance with other
      legal obligations, or truthful assertion of or defense against any claim
      of breach of this Agreement, or to his truthful statements or disclosures
      to officers or directors of the Company, and shall not require Floor to
      make false statements or
disclosures.

            

    

    

    
      	
               
      

            	
              b.

            	
              The
      Company agrees that neither it nor its affiliates,
      directors,  officers, nor employees of the Company nor any
      spokesperson for any of them shall make any disparaging statements about
      Floor; provided that the provisions of this clause shall not apply to
      truthful testimony as a witness, compliance with other legal obligations,
      truthful assertion of or defense against any claim of breach of this
      Agreement or truthful statements or disclosures to Floor, and shall not
      require false statements or disclosures to be
  made.

            

    

     

    

    
      
        
          
             

            

          

           

        

        
          Page
1 of 5

          
            

          

        

        
           

        

      

    

     

    
      
        	
                
                  5.

                

              	
                 

              	
                Releases.  Except
      for a claim based upon a breach of this Agreement and the performance of
      the obligations contained herein, effective as of the Closing Date Floor
      shall release the Released Parties (as defined below), and the Company
      shall release Floor, from any and all claims, suits, demands, actions or
      causes of action of any kind or nature whatsoever, whether the underlying
      facts are known or unknown, which Floor or the Released Parties have or
      now claim, or might have or claim, pertaining to or arising out of Floor’s
      employment by the Company or his separation therefrom, or any breach or
      non-performance of any employment or other agreements with Floor, or under
      any local, state or federal common law, statute, regulation or ordinance,
      including without limitation those claims dealing with employment
      discrimination, including without limitation, Title VII of the Civil
      Rights Act of 1964, as amended, 42 U.S.C. § 2000e et seq., 42 U.S.C. §
      1981, Americans with Disabilities Act, or claims for breach of contract,
      for breach of fiduciary duty, for misrepresentation, for defamation, for
      wrongful discharge under the common law of any state, for infliction of
      emotional distress or for any other tort under the common law of any
      state.  This release shall run to and be binding upon the
      Company and each of its affiliates, and all predecessors, successors and
      assigns thereof and each of their

              

      

       

    

    
      	
               
      

            	
              members,
      trustees, shareholders, partners, principals, members, directors,
      officers, trustees, employees, agents and attorneys, past or present, and
      all predecessors, successors, heirs and assigns thereof (collectively,
      "Released Parties").  This release shall also run to and be
      binding upon Floor, and all predecessors, successors and assigns thereof
      and each of his employees, agents and attorneys, past or present, and all
      predecessors, successors, heirs and assigns
  thereof.

            

    

     

    
      
        	
                6.

              	
                Covenant
      Not to Sue.  To the maximum extent permitted by law, as
      of the Closing Date, the Company and Floor covenant not to sue or to
      institute or cause to be instituted any action in any federal, state or
      local agency or court against the other party regarding the matters
      covered by the release contained in paragraph 5 above (except to enforce
      the terms of this Agreement).  If any party breaches the terms
      of the release and covenant not to sue, then the aggrieved party shall be
      entitled to recover its costs, including reasonable attorneys’ fees
      incurred in defending such action.

              

      

       

    

    
      
        	
                7.

              	
                Company
      Property.  Upon execution of this Agreement, Floor shall
      return all of the Company’s personal property to the Company, including
      all Confidential Information, books and records of the Company and any
      other property of the Company or its
affiliates.

              

      

    

    

    
      
        	
                8.

              	
                Modification.  No
      modification of this Agreement shall be valid unless signed by the party
      against whom such modification is sought to be
  enforced.

              

      

    

    

    
      
        	
                9.

              	
                Legal
      Counsel.  Floor acknowledges that he has carefully read
      and fully understands the terms and provisions of this Agreement and all
      of their rights and obligations thereunder, has had an opportunity to be
      represented by legal counsel of his choosing prior to executing this
      Agreement which contains a general release and waiver and that his
      execution of this Agreement is
voluntary.

              

      

    

    

    
      
        	
                10.

              	
                No
      Admission.  The parties agree that neither this Agreement
      nor performance hereunder constitutes an admission by any party of any
      violation of any federal, state or local law, regulation, common law, of
      any breach of any contract or any other wrongdoing of any
      type.

              

      

    

    

    
      
        	
                11.

              	
                Entire
      Agreement.  This instrument constitutes the entire
      agreement between the
parties.

              

      

    

    

    
      
        	
                12.

              	
                Severability.  If
      any provision, section, subsection or other portion of this Agreement
      shall be determined by any court of competent jurisdiction to be invalid,
      illegal or unenforceable in whole or in part, and such determination shall
      become final, such provision or portion shall be deemed to be severed or
      limited, but only to the extent required to render the remaining
      provisions and portions of this Agreement enforceable.  This
      Agreement as thus amended shall be enforced so as to give effect of the
      intention of the parties insofar as that is possible.  In
      addition, the parties hereby expressly empower a court of competent
      jurisdiction to modify any term or provision of this Agreement to the
      extent necessary to comply with existing law and to enforce this Agreement
      as modified.

              

      

    

    

    
      
        
          
            

          

           

        

        
          Page
2 of 5

          
            

          

        

        
           

        

      

    

    

    

    
      
        	
                13.

              	
                Governing
      Law.  This Agreement shall be construed in accordance
      with the laws of the State of
Colorado.

              

      

    

    

    
      
        	
                14.

              	
                Counterparts.  This
      Agreement may be signed in multiple counterparts, each of which shall be
      deemed to be an original for all
purposes.

              

      

    

    

    
      
        	
                15.

              	
                Term of
      Agreement.  This
      Agreement shall terminate, and be of no futher force or effect, if the
      Payment and Issuance is not completed in its entirety on or before
      February 27, 2009.  In the event this Agreement termintats as
      provided in this paragraph, the resignation of Floor pursuant to paragraph
      1 shall have no effect on the payment or other obligations of the Company
      or its successor under the Employment
Agreement.

              

      

    

    

    

    IN WITNESS WHEREOF, the
parties have executed this Agreement on the date first above
written.

    

    

    
      
        
          
            
              
                
                  
                    	 	
                            Apro
      Bio Pharmaceutical Corporation

                          	 
	 	 	 	 
	
                             

                          	
                            By:   
      

                          	/s/ Vicki D.E.
      Barone__________________	 
	 	
                            Printed
      Name:   

                          	
                            Vicki
      D.E. Barone____________________

                          	 
	 	
                            Its:  
      

                          	Chair______________________________	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	
                            Name:   

                          	 David Floor_________________________	 

                  

                

              

            

          

        

      

    

    
      
      

    

     

    

      
        
           

        

        
          Page
3 of 5

          
            

          

        

        
           

        

      

       

       

      AMENDMENT
TO SETTLEMENT AGREEMENT

      

      This
Amendment, entered into this 24th day of February, 2009, modifies the Agreement
by and among Apro Bio Pharmaceuticals Corporation (the “Company”) and Dave Floor
(“Floor”) dated January 8, 2009 (the “Settlement Agreement”).

      

      WHEREAS,
the Parties desire to amend the Settlement Agreement as set forth below, for the
purposes of extending the term of Agreement until after the Company’s pending
merger with Across America Financial Services, Inc.

      

      NOW
THEREFORE, the Company and Floor agree to amend the Agreement as
follows:

      

      Section
15 Term of Agreement is amended so that “February 27, 2009” is deleted and
replaced with “March 16, 2009”.

      

      All of
the terms and conditions of the original Agreement and Schedules remain in full
effect, unless specifically modified by the terms herein.

      

      IN
WITNESS WHEREOF, the parties hereto hereby execute this Amendment by their duly
authorized representatives on the dates set forth below.

       

      
        

        
          
            
              	
                      /s/ Dave Floor
      ________________________

                    	 
      
	
                      Dave
      Floor

                    	
                      Date                                              
      

                    
	 
      	 
      
	 
      	 
      
	 
      	 
      
	
                      /s/ Vicki D. E. Barone
      __________________

                    	 
      
	
                      Vicki
      D. E. Barone

                    	
                      Date                                               
                                                   
      

                    
	
                      Chairman
      of the Board

                    	 
      
	
                      Apro
      Bio Pharmaceutical Corporation

                    	 
      

            

             

          

        

        

          
            
               

            

            
              Page
4 of 5

              
                

              

            

            
               

            

          

          SECOND
AMENDMENT TO SETTLEMENT AGREEMENT

          

          This
Second Amendment, entered into this 16th day of March, 2009, modifies the
Agreement by and among Apro Bio Pharmaceuticals Corporation (the “Company”) and
Dave Floor (“Floor”) dated January 8, 2009 (the “Settlement Agreement”) and the
Amendment to Settlement Agreement dated February 24, 2009.

          

          WHEREAS,
the Parties desire to amend the Settlement Agreement as set forth below, for the
purposes of extending the term of Agreement until after the Company’s pending
merger with Across America Financial Services, Inc.

          

          NOW
THEREFORE, the Company and Floor agree to amend the Agreement as
follows:

          

          Section
15 Term of Agreement is amended so that “March 16, 2009” is deleted and replaced
with “April 1, 2009”.

          

          All of
the terms and conditions of the original Agreement and Schedules remain in full
effect, unless specifically modified by the terms herein.

          

          IN
WITNESS WHEREOF, the parties hereto hereby execute this Amendment by their duly
authorized representatives on the dates set forth below.

        

        
           

          
            

            
              
                
                  	
                          /s/ Dave Floor
      ________________________

                        	 
      
	
                          Dave
      Floor

                        	
                          Date                                              
      

                        
	 
      	 
      
	 
      	 
      
	 
      	 
      
	
                          /s/ Vicki D. E. Barone
      __________________

                        	 
      
	
                          Vicki
      D. E. Barone

                        	
                          Date                                               
                                                   
      

                        
	
                          Chairman
      of the Board

                        	 
      
	
                          Apro
      Bio Pharmaceutical Corporation

                        	 
      

                

                 

                Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]